Cara Therapeutics reported $-23180000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Acelrx Pharmaceuticals ACRX:US USD -6750000 77.41M
Cara Therapeutics CARA:US USD -23180000 18.97M
Chugai Pharma 4519:JP JPY 102.48B 34.68B
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Horizon Pharma HZNP:US USD 135.84M 74.86M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Johnson & Johnson JNJ:US USD 3.52B 938M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Pain Therapeutics PTIE:US USD -20257000 929K
Pfizer PFE:US USD 5B 3.61B
Revance Therapeutics RVNC:US USD -84693000 23.26M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M